Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Pravin Kaumaya

Professor, Vaccine Development/Peptide & Protein Engineering Laboratory at The Ohio State University Wexner Medical Center and the James Hospital and Comprehensive Cancer Center


Dr Kaumaya is Professor of Medicine in Department of Ob/Gyn at the OSU Wexner Medical Center and the James Comprehensive Cancer Center. Dr Kaumaya is internationally recognized as an expert in the fields of vaccine research with emphasis on peptide vaccines for cancer, viral diseases as well as peptide therapy for autoimmune diseases. He conducts research in the areas of tumor immunology, mechanisms of tumor cell-immune cell interactions, and immune mechanisms. The laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic strategies for cancer treatment and prevention.  He is an inventor on several issued and pending patents for Peptide Vaccines and Therapeutic Technologies.   He has lectured worldwide and has published over 130 peer-reviewed articles in major scientific journals Dr. Kaumaya is an elected fellow of the American Association for the Advancement of Science (AAAS), and he was elected as the treasurer of the American Peptide Society since 2009. Dr Kaumaya has conducted  a first man/woman NCI funded and FDA approved Phase 1 Trial in Cancer Patients (Stage 4) with solid tumors in several indications (Breast, Ovarian, GIST) at the OSU James Cancer Hospital has recently been completed successfully

Agenda Sessions